Clinical course of MOG antibody-associated recurrent demyelinating diseases
- PMID: 29175896
- DOI: 10.1136/jnnp-2017-317249
Clinical course of MOG antibody-associated recurrent demyelinating diseases
Keywords: multiple sclerosis; neuroimmunology.
Conflict of interest statement
Competing interests: The Neurological Research Laboratory (Medical University of Innsbruck and Tirol Kliniken, Innsbruck, Austria) receives payments for antibody assays (AQP4 and antineuronal antibodies) and for MOG and AQP4 antibody validation experiments organised by Euroimmun (Germany).
Comment on
-
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination.J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):127-137. doi: 10.1136/jnnp-2017-316880. Epub 2017 Nov 15. J Neurol Neurosurg Psychiatry. 2018. PMID: 29142145 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources